Andrew Booth, CFO at AbCellera Biologics, holds 326.56K shares in AbCellera Biologics (Ticker: ABCL). Most recently, Andrew Booth Bought 42,600 shares of AbCellera Biologics on Feb 27, 2026 for an estimated value of $145.69K.
What is the percentage of profitable transactions made by Andrew Booth?
The percentage of profitable transactions made by Andrew Booth is 0%.
What is the average return per transaction made by Andrew Booth?
The average return per transaction made by Andrew Booth is -20.40%.
What stocks does Andrew Booth hold?
Andrew Booth holds: ABCL stocks.
What was Andrew Booth’s latest transaction?
Andrew Booth latest transaction was an Informative Buy of $145.69K.
What was Andrew Booth's most profitable transaction?
Andrew Booth’s most profitable transaction was an Informative Buy of ABCL stock on February 27, 2026. The return on the trade was 0.00%.
What is Andrew Booth's role in AbCellera Biologics?
Andrew Booth's role in AbCellera Biologics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.